Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration

Author:

El-Remessy Azza B.12,Bartoli Manuela13,Platt Danial H.1,Fulton David12,Caldwell Ruth B.145

Affiliation:

1. Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA

2. Department of Pharmacology, Medical College of Georgia, Augusta, GA 30912, USA

3. Department of Pathology, Medical College of Georgia, Augusta, GA 30912, USA

4. Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta, GA 30912, USA

5. Department of Ophthalmology, Medical College of Georgia, Augusta, GA 30912, USA

Abstract

In diabetic retinopathy, endothelial cell apoptosis is paradoxically increased despite upregulation of the potent pro-survival factor VEGF. We tested the hypothesis that elevated glucose levels disrupt VEGF's pro-survival function via peroxynitrite-mediated alteration of the Akt-1/p38 MAP kinase signaling pathway by studies of retinal endothelial cells in vitro. High glucose or exogenous peroxynitrite caused significant increases in apoptosis in the presence or absence of VEGF. Treatment with a peroxynitrite decomposition catalyst blocked these effects, implying a causal role of peroxynitrite. Peroxynitrite or high glucose treatment also increased phosphorylation of p38 MAP kinase, whereas phosphorylation of Akt-1 was significantly decreased in basal or VEGF-stimulated conditions. High glucose- or peroxynitrite-treated cells also showed significant increases in tyrosine nitration on the p85 subunit of PI 3-kinase that blocked PI 3-kinase and Akt-1 kinase activity. Inhibiting peroxynitrite formation or blocking tyrosine nitration of p85 restored the activity of PI 3-kinase and Akt-1 kinase, blocked phosphorylation of p38 MAP kinase and normalized pro-survival function. Transfecting the cells with constitutively active Akt-1 or inhibiting activity of p38 MAP kinase completely masked the pro-apoptotic effects of high glucose and exogenous peroxynitrite, suggesting an interaction between the Akt-1 and p38 MAP kinase pathways. In conclusion, high glucose treatment blocks the pro-survival effect of VEGF and causes accelerated endothelial cell apoptosis via the action of peroxynitrite in causing tyrosine nitration of PI 3-kinase, inhibiting activity of Akt-1 kinase and increasing the activity of p38 MAP kinase.

Publisher

The Company of Biologists

Subject

Cell Biology

Reference53 articles.

1. Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E. et al. (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med.331, 1480-1487.

2. Baumgartner-Parzer, S. M., Wagner, L., Pettermann, M., Grillari, J., Gessl, A. and Waldhausl, W. (1995). High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes44, 1323-1327.

3. Behzadian, M. A., Wang, X. L., Shabrawey, M. and Caldwell, R. B. (1998). Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia24, 216-225.

4. Behzadian, M. A., El-Remessy, A., Franklin, T. and Caldwell, R. B. (2003). High glucose induces urokinase receptor (uPAR) expression in vascular endothelial cells through the GSK3/β-catenine pathway. Invest. Ophthalmol. Vis. Sci.44, 3905.

5. Brooks, S. E., Gu, X., Samuel, S., Marcus, D. M., Bartoli, M., Huang, P. L. and Caldwell, R. B. (2001). Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest. Ophthalmol. Vis. Sci.42, 222-228.

Cited by 123 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3